Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aß-Induced Neurodegeneration and Synaptic Impairment

The p75 neurotrophin receptor (p75NTR) is expressed by neurons particularly vulnerable in Alzheimer’s disease (AD). We tested\r\nthe hypothesis that non-peptide, small molecule p75NTR ligands found to promote survival signaling might prevent Abinduced\r\ndegeneration and synaptic dysfunction. These ligands inhibited Ab-induced neuritic dystrophy, death of cultured\r\nneurons and Ab-induced death of pyramidal neurons in hippocampal slice cultures. Moreover, ligands inhibited Ab-induced\r\nactivation of molecules involved in AD pathology including calpain/cdk5, GSK3b and c-Jun, and tau phosphorylation, and\r\nprevented Ab-induced inactivation of AKT and CREB. Finally, a p75NTR ligand blocked Ab-induced hippocampal LTP\r\nimpairment. These studies support an extensive intersection between p75NTR signaling and Ab pathogenic mechanisms, and\r\nintroduce a class of specific small molecule ligands with the unique ability to block multiple fundamental AD-related signaling\r\npathways, reverse synaptic impairment and inhibit Ab-induced neuronal dystrophy and death. Originally published PLoS ONE, Vol. 3, No. 11, Nov 200